LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.31 | 27.76 | 4356 | 6976 | 0.6244 | 0.8853 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.01 | 27.76 | 4583 | 7000 | 0.6547 | 0.8966 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.01 | 27.76 | 4601 | 7000 | 0.6573 | 0.8975 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.01 | 27.76 | 904 | 7000 | 0.1291 | 0.5474 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.01 | 27.76 | 4444 | 7000 | 0.6348 | 0.8893 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 83.72 | 27.76 | 4693 | 7055 | 0.6651 | 0.9005 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 83.72 | 27.76 | 4711 | 7055 | 0.6677 | 0.9014 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 83.72 | 27.76 | 1059 | 7055 | 0.1501 | 0.5774 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 83.72 | 27.76 | 4707 | 7055 | 0.6671 | 0.9012 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 85.42 | 27.76 | 4881 | 7025 | 0.6947 | 0.9108 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 85.42 | 27.76 | 4901 | 7025 | 0.6976 | 0.9118 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 85.42 | 27.76 | 1023 | 7025 | 0.1456 | 0.5711 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 85.42 | 27.76 | 4806 | 7025 | 0.6841 | 0.9071 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.13 | 27.76 | 5055 | 6987 | 0.7234 | 0.9204 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.13 | 27.76 | 5071 | 6987 | 0.7257 | 0.9212 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.13 | 27.76 | 1104 | 6987 | 0.1580 | 0.5869 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.13 | 27.76 | 5016 | 6987 | 0.7178 | 0.9186 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.84 | 27.76 | 5256 | 6965 | 0.7546 | 0.9306 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.84 | 27.76 | 5272 | 6965 | 0.7569 | 0.9313 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.84 | 27.76 | 1148 | 6965 | 0.1648 | 0.5952 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.84 | 27.76 | 5130 | 6965 | 0.7365 | 0.9247 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.55 | 27.76 | 5418 | 6928 | 0.7820 | 0.9392 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.55 | 27.76 | 5438 | 6928 | 0.7849 | 0.9401 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.55 | 27.76 | 1267 | 6928 | 0.1829 | 0.6158 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 90.55 | 27.76 | 5340 | 6928 | 0.7707 | 0.9357 | MN20160318_Q01 | N13 |